3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2964
Carcinoma, Renal Cell
881
Urinary Bladder Neoplasms
710
Kidney Neoplasms
457
Breast Neoplasms
408
Neoplasms
390
Neoplasm Metastasis
229
Carcinoma, Non-Small-Cell Lung
229
Lung Neoplasms
216
Ovarian Neoplasms
211
Colorectal Neoplasms
204
Melanoma
195
Carcinoma, Transitional Cell
189
Testicular Neoplasms
170
Pancreatic Neoplasms
142
Sarcoma
129
Head and Neck Neoplasms
121
Colonic Neoplasms
120
Wilms Tumor
116
Uterine Cervical Neoplasms
116
Stomach Neoplasms
98
Neuroblastoma
90
Multiple Myeloma
88
Lymphoma, Non-Hodgkin
86
Esophageal Neoplasms
86
Lymphoma
83
Carcinoma, Hepatocellular
81
Carcinoma, Ovarian Epithelial
80
Recurrence
75
Squamous Cell Carcinoma of Head and Neck
74
Interventions
enzalutamide
1
darolutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Biochemically Recurrent Prostate Cancer
×
Genitourinary
×
Clear all
NCT05526248
2026-03-11
ARAMON
Bayer
Phase 2
Completed
28 enrolled
14 charts